BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $684,000 | -13.2% | 4,511 | -16.6% | 0.00% | 0.0% |
Q2 2022 | $788,000 | +19.0% | 5,406 | -3.1% | 0.00% | 0.0% |
Q1 2022 | $662,000 | +0.3% | 5,580 | +25.2% | 0.00% | 0.0% |
Q4 2021 | $660,000 | -73.3% | 4,458 | -75.0% | 0.00% | -66.7% |
Q3 2021 | $2,471,000 | +465.4% | 17,811 | +296.2% | 0.00% | +200.0% |
Q2 2021 | $437,000 | +54.4% | 4,496 | +8.4% | 0.00% | – |
Q1 2021 | $283,000 | -18.9% | 4,146 | +1.9% | 0.00% | -100.0% |
Q4 2020 | $349,000 | +33.7% | 4,069 | +1.4% | 0.00% | – |
Q3 2020 | $261,000 | +14.0% | 4,013 | +28.0% | 0.00% | – |
Q2 2020 | $229,000 | -77.3% | 3,134 | -87.0% | 0.00% | -100.0% |
Q3 2019 | $1,009,000 | -72.3% | 24,188 | -70.9% | 0.00% | -66.7% |
Q2 2019 | $3,645,000 | – | 83,217 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |